NM_001370259.2(MEN1):c.196A>C (p.Ser66Arg) AND Multiple endocrine neoplasia, type 1

Germline classification:: Uncertain significance (2 submissions)
Last evaluated:: Jan 14, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001364873.6

Allele description [Variation Report for NM_001370259.2(MEN1):c.196A>C (p.Ser66Arg)]

NM_001370259.2(MEN1):c.196A>C (p.Ser66Arg)

Gene:

MEN1:menin 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

11q13.1

Genomic location:

Preferred name:

NM_001370259.2(MEN1):c.196A>C (p.Ser66Arg)

HGVS:

NC_000011.10:g.64809914T>G
NG_008929.1:g.6381A>C
NM_000244.4:c.196A>C
NM_001370251.2:c.196A>C
NM_001370259.2:c.196A>CMANE SELECT
NM_001370260.2:c.196A>C
NM_001370261.2:c.196A>C
NM_001370262.2:c.196A>C
NM_001370263.2:c.196A>C
NM_130799.2:c.196A>C
NM_130799.3:c.196A>C
NM_130800.3:c.196A>C
NM_130801.3:c.196A>C
NM_130802.3:c.196A>C
NM_130803.3:c.196A>C
NM_130804.3:c.196A>C
NP_000235.3:p.Ser66Arg
NP_001357180.2:p.Ser66Arg
NP_001357188.2:p.Ser66Arg
NP_001357189.2:p.Ser66Arg
NP_001357190.2:p.Ser66Arg
NP_001357191.2:p.Ser66Arg
NP_001357192.2:p.Ser66Arg
NP_570711.2:p.Ser66Arg
NP_570712.2:p.Ser66Arg
NP_570713.2:p.Ser66Arg
NP_570714.2:p.Ser66Arg
NP_570715.2:p.Ser66Arg
NP_570716.2:p.Ser66Arg
LRG_509t2:c.196A>C
LRG_509:g.6381A>C
NC_000011.9:g.64577386T>G

Protein change:

S66R

Links:

dbSNP: rs1942005110

NCBI 1000 Genomes Browser:

rs1942005110

Molecular consequence:

NM_000244.4:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001370251.2:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001370259.2:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001370260.2:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001370261.2:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001370262.2:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001370263.2:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_130799.3:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_130800.3:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_130801.3:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_130802.3:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_130803.3:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_130804.3:c.196A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Multiple endocrine neoplasia, type 1 (MEN1)
Synonyms:: MEA I; MEN I; Endocrine adenomatosis multiple; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0007540; MeSH: D018761; MedGen: C0025267; Orphanet: 652; OMIM: 131100

Recent activity

Clear Turn Off Turn On

Membrane-bound lytic murein transglycosylase E [Klebsiella aerogenes]
Membrane-bound lytic murein transglycosylase E [Klebsiella aerogenes]
gi|1539302823|emb|VDZ67482.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001561067	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jan 14, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV004194469	Baylor Genetics	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Jul 21, 2023)	unknown	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001561067

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jan 14, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004194469

Baylor Genetics

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Jul 21, 2023)

unknown

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001561067.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 66 of the MEN1 protein (p.Ser66Arg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MEN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1056099). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MEN1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Baylor Genetics, SCV004194469.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine